Simmons & Simmons: Licensing Deals and Acquisitions: A Legal Insight




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Simmons & Simmons: Licensing Deals and Acquisitions: A Legal Insight
Released on: November 01, 2007. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks live from Geneva to Marc Fredj and Richard Wallis, Associates in the Life Sciences Group at Simmons & Simmons.
  • Summary
  • Participants
  • Company
Fintan Walton talks live from Geneva to Marc Fredj and Richard Wallis, Associates in the Life Sciences Group at Simmons & Simmons. Specifically, the interview gives a legal perspective on licensing and M&As within the life sciences industry. The interview commences with a discussion on a recent Simmons and Simmons report which focuses on trends in the licensing deals and acquisitions that are taking place in the industry. Among the issues discussed is the increase in the number of earlier stage licensing deals. Marc talks about how the bargaining power in structuring a deal is shifting more towards the smaller biotechs, and the reasons why this may be so. The participants discuss how the geography of a licensing deal will, increasingly, incorporate the entire world, rather than a few countries. They also deliberate on the increase in the number of acquisitions involving biotechs, which is a recent trend, and consider the challenges that may arise in such transactions – challenges of which biotechs need to be aware should they partake in an acquisition. The differences between the due diligence carried out for a licensing deal compared with the process for an acquisition deal are discussed, as well as reasons why acquisitions are the more favoured deal type for the moment. Litigation issues in the industry are also covered, followed by a discussion on whether deals are becoming more complex – in terms of both financing and IP.
Marc Fredj

Marc’s experience is focused on cross-border transactions, but also includes corporate law and M&As. He has advised public as well as private companies, and has gained exposure to all aspects of several forms of stock purchases and exchanges, assets deals and venture capital investments. Marc holds a postgraduate degree in Business and Economic Law from Paris University I and a LLM degree from Georgetown University.

Richard Wallis

Richard’s area of speciality lies in all aspects of non-contentious and contentious IP law. He has extensive experience in drafting and negotiating technology transfer, collaboration, licensing and development and other commercial agreements. Richard advises on competition law and regulatory matters, as well as on IP and regulatory aspects of corporate finance. He is also experienced in patent, copyright and trade mark infringement cases, and passing-off actions. Richard graduated from Bristol University with degrees in science and in law before training as a solicitor with Simmons & Simmons.
Simmons & Simmons